Cargando…

A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193)

BACKGROUND: Diabetes is a common disease with self-management a key aspect of care. Large prospective trials have shown that maintaining glycated hemoglobin less than 7% greatly reduces complications but translating this level of control into everyday clinical practice can be difficult. Intensive im...

Descripción completa

Detalles Bibliográficos
Autores principales: Huizinga, Mary Margaret, Shintani, Ayumi, Michon, Stephanie, Brown, Anne, Wolff, Kathleen, Shackleford, Laurie, King, Elaine Boswell, Gregory, Rebecca Pratt, Davis, Dianne, Stiles, Renee, Gebretsadik, Tebeb, Chen, Kong, Rothman, Russell, Pichert, James W, Schlundt, David, Elasy, Tom A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634866/
https://www.ncbi.nlm.nih.gov/pubmed/17054790
http://dx.doi.org/10.1186/1748-5908-1-24
_version_ 1782130650906624000
author Huizinga, Mary Margaret
Shintani, Ayumi
Michon, Stephanie
Brown, Anne
Wolff, Kathleen
Shackleford, Laurie
King, Elaine Boswell
Gregory, Rebecca Pratt
Davis, Dianne
Stiles, Renee
Gebretsadik, Tebeb
Chen, Kong
Rothman, Russell
Pichert, James W
Schlundt, David
Elasy, Tom A
author_facet Huizinga, Mary Margaret
Shintani, Ayumi
Michon, Stephanie
Brown, Anne
Wolff, Kathleen
Shackleford, Laurie
King, Elaine Boswell
Gregory, Rebecca Pratt
Davis, Dianne
Stiles, Renee
Gebretsadik, Tebeb
Chen, Kong
Rothman, Russell
Pichert, James W
Schlundt, David
Elasy, Tom A
author_sort Huizinga, Mary Margaret
collection PubMed
description BACKGROUND: Diabetes is a common disease with self-management a key aspect of care. Large prospective trials have shown that maintaining glycated hemoglobin less than 7% greatly reduces complications but translating this level of control into everyday clinical practice can be difficult. Intensive improvement programs are successful in attaining control in patients with type 2 diabetes, however, many patients experience glycemic relapse once returned to routine care. This early relapse is, in part, due to decreased adherence in self-management behaviors. OBJECTIVE: This paper describes the design of the Glycemic Relapse Prevention study. The purpose of this study is to determine the optimal frequency of maintenance intervention needed to prevent glycemic relapse. The primary endpoint is glycemic relapse, which is defined as glycated hemoglobin greater than 8% and an increase of 1% from baseline. METHODS: The intervention consists of telephonic contact by a nurse practitioner with a referral to a dietitian if indicated. This intervention was designed to provide early identification of self-care problems, understanding the rationale behind the self-care lapse and problem solve to find a negotiated solution. A total of 164 patients were randomized to routine care (least intensive), routine care with phone contact every three months (moderate intensity) or routine care with phone contact every month (most intensive). CONCLUSION: The baseline patient characteristics are similar across the treatment arms. Intervention fidelity analysis showed excellent reproducibility. This study will provide insight into the important but poorly understood area of glycemic relapse prevention.
format Text
id pubmed-1634866
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-16348662006-11-07 A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193) Huizinga, Mary Margaret Shintani, Ayumi Michon, Stephanie Brown, Anne Wolff, Kathleen Shackleford, Laurie King, Elaine Boswell Gregory, Rebecca Pratt Davis, Dianne Stiles, Renee Gebretsadik, Tebeb Chen, Kong Rothman, Russell Pichert, James W Schlundt, David Elasy, Tom A Implement Sci Study Protocol BACKGROUND: Diabetes is a common disease with self-management a key aspect of care. Large prospective trials have shown that maintaining glycated hemoglobin less than 7% greatly reduces complications but translating this level of control into everyday clinical practice can be difficult. Intensive improvement programs are successful in attaining control in patients with type 2 diabetes, however, many patients experience glycemic relapse once returned to routine care. This early relapse is, in part, due to decreased adherence in self-management behaviors. OBJECTIVE: This paper describes the design of the Glycemic Relapse Prevention study. The purpose of this study is to determine the optimal frequency of maintenance intervention needed to prevent glycemic relapse. The primary endpoint is glycemic relapse, which is defined as glycated hemoglobin greater than 8% and an increase of 1% from baseline. METHODS: The intervention consists of telephonic contact by a nurse practitioner with a referral to a dietitian if indicated. This intervention was designed to provide early identification of self-care problems, understanding the rationale behind the self-care lapse and problem solve to find a negotiated solution. A total of 164 patients were randomized to routine care (least intensive), routine care with phone contact every three months (moderate intensity) or routine care with phone contact every month (most intensive). CONCLUSION: The baseline patient characteristics are similar across the treatment arms. Intervention fidelity analysis showed excellent reproducibility. This study will provide insight into the important but poorly understood area of glycemic relapse prevention. BioMed Central 2006-10-20 /pmc/articles/PMC1634866/ /pubmed/17054790 http://dx.doi.org/10.1186/1748-5908-1-24 Text en Copyright © 2006 Huizinga et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Huizinga, Mary Margaret
Shintani, Ayumi
Michon, Stephanie
Brown, Anne
Wolff, Kathleen
Shackleford, Laurie
King, Elaine Boswell
Gregory, Rebecca Pratt
Davis, Dianne
Stiles, Renee
Gebretsadik, Tebeb
Chen, Kong
Rothman, Russell
Pichert, James W
Schlundt, David
Elasy, Tom A
A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193)
title A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193)
title_full A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193)
title_fullStr A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193)
title_full_unstemmed A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193)
title_short A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193)
title_sort randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: study protocol (nct00362193)
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634866/
https://www.ncbi.nlm.nih.gov/pubmed/17054790
http://dx.doi.org/10.1186/1748-5908-1-24
work_keys_str_mv AT huizingamarymargaret arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT shintaniayumi arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT michonstephanie arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT brownanne arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT wolffkathleen arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT shacklefordlaurie arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT kingelaineboswell arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT gregoryrebeccapratt arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT davisdianne arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT stilesrenee arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT gebretsadiktebeb arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT chenkong arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT rothmanrussell arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT pichertjamesw arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT schlundtdavid arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT elasytoma arandomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT huizingamarymargaret randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT shintaniayumi randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT michonstephanie randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT brownanne randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT wolffkathleen randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT shacklefordlaurie randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT kingelaineboswell randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT gregoryrebeccapratt randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT davisdianne randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT stilesrenee randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT gebretsadiktebeb randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT chenkong randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT rothmanrussell randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT pichertjamesw randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT schlundtdavid randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193
AT elasytoma randomizedcontrolledtrialtopreventglycemicrelapseinlongitudinaldiabetescarestudyprotocolnct00362193